The Kamal Joumblatt Award for 2018, allocated this year to the field of combating cancer and its growing risks in Lebanon, was presented to AUB's Dr. Ali Bazarbachi, in an award ceremony that took place on March 14, 2019.
Dr. Bazarbachi serves as associate dean for basic research; professor of medicine, hematology, and oncology; professor of anatomy, cell biology, and physiological sciences at AUB. He is also the director of the Bone Marrow Transplantation Program at AUB Medical Center, which he had initiated, and which is the largest of its kind in Lebanon. His research revolves around developing targeted therapies for leukemia and lymphoma and bone marrow transplantation.
“Cancer is a contemporary disease, and the percentage of cancer is increasing in Lebanon as it is in the rest of the world. The reasons for this increase are numerous, including the development of society, the increase in age median, lifestyle changes, smoking and environmental pollution," said Dr. Bazarbachi in his acceptance speech. “The fight against cancer comes only through scientific research aimed at knowing its causes and prevention, and the development of targeted therapies that lead to the healing of the largest number of patients while maintaining the quality of life and alleviating the side effects of the disease."
Dr. Bazarbachi continued speaking about the limited participation of the Arab world in scientific research and the production of knowledge at the global level, stressing that “scientific research is the way to fight cancer. It is an investment in the future and in generations to come."
The Kamal Joumblatt Award is an independent award established in 2011 by the Friends of Kamal Joumblatt Association. It is granted every two years in accordance with objective scientific criteria, to be determined by a specialized committee.
In addition to the latest Kamal Joumblatt Award for the year 2018, Dr. Bazarbachi has received numerous national and international prizes and awards for his groundbreaking research and efforts in several areas. These include the Hafez Kobeissi Prize for Excellence in Scientific Research, the French League Against Cancer Prize for Cancer Research, and the 2008 award of the French National Academy of Medicine.